EORTC trial 11001: distribution of two 10B-compounds in patients with squamous cell carcinoma of head and neck, a translational research/phase 1 trial.
about
Metalloid compounds as drugsQuo vadis radiotherapy? Technological advances and the rising problems in cancer managementAdvancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy.Assessment of 10B concentration in boron neutron capture therapy: potential of image-guided therapy using 18FBPA PET.A Hypoxia-Targeted Boron Neutron Capture Therapy Agent for the Treatment of Glioma
P2860
EORTC trial 11001: distribution of two 10B-compounds in patients with squamous cell carcinoma of head and neck, a translational research/phase 1 trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
EORTC trial 11001: distributio ...... tional research/phase 1 trial.
@en
EORTC trial 11001: distributio ...... tional research/phase 1 trial.
@nl
type
label
EORTC trial 11001: distributio ...... tional research/phase 1 trial.
@en
EORTC trial 11001: distributio ...... tional research/phase 1 trial.
@nl
prefLabel
EORTC trial 11001: distributio ...... tional research/phase 1 trial.
@en
EORTC trial 11001: distributio ...... tional research/phase 1 trial.
@nl
P2093
P2860
P1476
EORTC trial 11001: distributio ...... tional research/phase 1 trial.
@en
P2093
Andrea Wittig
Karl-Heinz Jöckel
Klaas Appelman
Kurt Werner Schmid
Laurence Collette
Martin C Jäckel
Raymond Moss
Sandra Bührmann
Uta Ortmann
Wolfgang A G Sauerwein
P2860
P304
P356
10.1111/J.1582-4934.2009.00856.X
P577
2009-07-10T00:00:00Z